- Home
- INKT vs CCM Comparison
INKT vs CCM Comparison
Compare INKT & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- CCM
- Stock Information
- Founded
- INKT 2017
- CCM 1997
- Country
- INKT United States
- CCM China
- Employees
- INKT N/A
- CCM N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- CCM Medical/Nursing Services
- Sector
- INKT Health Care
- CCM Health Care
- Exchange
- INKT Nasdaq
- CCM Nasdaq
- Market Cap
- INKT 28.8M
- CCM 33.3M
- IPO Year
- INKT 2021
- CCM 2009
- Fundamental
- Price
- INKT $41.04
- CCM $5.22
- Analyst Decision
- INKT Strong Buy
- CCM
- Analyst Count
- INKT 2
- CCM 0
- Target Price
- INKT $37.50
- CCM N/A
- AVG Volume (30 Days)
- INKT 2.4M
- CCM 1.8K
- Earning Date
- INKT 08-12-2025
- CCM 04-25-2025
- Dividend Yield
- INKT N/A
- CCM N/A
- EPS Growth
- INKT N/A
- CCM N/A
- EPS
- INKT N/A
- CCM N/A
- Revenue
- INKT N/A
- CCM $52,603,198.00
- Revenue This Year
- INKT N/A
- CCM N/A
- Revenue Next Year
- INKT N/A
- CCM N/A
- P/E Ratio
- INKT N/A
- CCM N/A
- Revenue Growth
- INKT N/A
- CCM N/A
- 52 Week Low
- INKT $4.56
- CCM $3.80
- 52 Week High
- INKT $76.00
- CCM $10.50
- Technical
- Relative Strength Index (RSI)
- INKT 69.01
- CCM 33.93
- Support Level
- INKT $6.80
- CCM $5.50
- Resistance Level
- INKT $76.00
- CCM $5.68
- Average True Range (ATR)
- INKT 4.65
- CCM 0.18
- MACD
- INKT 4.24
- CCM 0.00
- Stochastic Oscillator
- INKT 49.48
- CCM 21.79
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.